Fig. 2
From: Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
Effect of brusatol and anticancer drugs on the HCV RNA level. a-b qRT-PCRs for HCV RNA in the HPI cells. The value for HCV RNA was normalized by the value for GAPDH RNA and is presented as fold change to that of control. Statistical significance *: p < 0.01, **: p < 0.001, ***: p < 0.0001 versus 0 nM or control. a qRT-PCRs after the administration of brusatol. b qRT-PCRs after the administration of agents at a concentration for the GI50 (80 nM, 4.3 μg/ml, 2.0 μg/ml and 8.0 μM for brusatol, CDDP, MMC and sorafenib, respectively)